SYNGEN BIOTECH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 153 TWD | +0.66% |
|
-1.29% | +0.66% |
| Sales 2024 * | 1.93B 59.92M 4.71B | Sales 2025 * | 2.02B 62.93M 4.95B | Capitalization | 4.15B 129M 10.14B |
|---|---|---|---|---|---|
| Net income 2024 * | 307M 9.55M 751M | Net income 2025 * | 324M 10.07M 792M | EV / Sales 2024 * | 2.15 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.05 x |
| P/E ratio 2024 * |
13.5
x | P/E ratio 2025 * |
12.8
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 34.08% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.66% | ||
| 1 week | -1.29% | ||
| Current month | +2.00% | ||
| 3 months | +3.38% | ||
| 6 months | +0.99% | ||
| Current year | +0.66% |
1 week
152.00
155.00
1 month
149.00156.00
Current year
148.00163.00
1 year
148.00191.50
3 years
83.50197.00
5 years
73.60197.00
10 years
26.78197.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Jen Chen
CEO | Chief Executive Officer | - | 30/06/05 |
Tzu Hui Wang
DFI | Director of Finance/CFO | - | - |
San Ho Tsai
ADM | Chief Administrative Officer | - | 28/02/13 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chin Tsai Fan
BRD | Director/Board Member | - | 27/04/99 |
Tzu Ting Fan
BRD | Director/Board Member | - | 28/06/07 |
Wu Hsiung Chuang
BRD | Director/Board Member | - | 18/04/16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/05/24 | 153 | +0.66% | 1,402 |
| 16/05/24 | 152 | -0.65% | 2,559 |
| 15/05/24 | 153 | -1.29% | 4,000 |
| 13/05/24 | 155 | 0.00% | 5,294 |
| 10/05/24 | 155 | +2.99% | 13,804 |
End-of-day quote Taipei Exchange, May 16, 2024
More quotes
Syngen Biotech Co Ltd is a Taiwan-based company mainly engaged in the manufacture and distribution of active pharmaceutical ingredients and health food products. The Companyâs products mainly consist of active pharmaceutical ingredients, health food raw materials, medical equipment, such as bone density analyzers, blood glucose analyzers and biochemical analyzers, as well as animal health products and others. The Company distributes its products mainly in Taiwan, Iran, South Korea and Egypt.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
153
TWD
Average target price
170
TWD
Spread / Average Target
+11.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.66% | 129M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +14.25% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- 8279 Stock
